Genincode Plc (GENI)
LSE
Real-time Data
07:00 AM
Day's Range
0.900052 wk Range
0.7500Overview - GENI - Genincode Plc
Key Statistics
Valuation
Enterprise Value
7.03M
P/E (Trailing)
‪-49.27‬
P/E (Forward)
‪-1.46‬
PEG Ratio
‪-1.46‬
Price / Sales (TTM)
‪2.50‬
EV / EBITDA
‪-1.23‬
Profitability
Profit Margin
‪-185.46%‬
Operating Margin
‪-230.39%‬
Return on Assets
‪-146.15%‬
Return on Equity
‪-912.07%‬
Ownership
Shares Outstanding
286.88M
Float
372.13M
Held by Insiders
‪32.66%‬
Held by Institutions
‪21.28%‬
Price stats
Beta
‪0.59‬
50-Day Avg
‪0.8771‬
200-Day Avg
‪1.29‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - GENI - Genincode Plc
Peers - GENI - Genincode Plc
Peer Comparison
Compared with companies in Diagnostics & Research listed on LSE.
- GENILSEGenincode Plc771.86MMarket Cap-36.59%52-week change-49.28P/E (Trailing)‪-185.46%‬Profit Margin
- SHCLSEShaftesbury Capital PLC270.76BMarket Cap+0.68%52-week change7.20P/E (Trailing)‪156.72%‬Profit Margin
- MTOLSEMitie Group plc262.06BMarket Cap+34.38%52-week change34.77P/E (Trailing)‪1.47%‬Profit Margin
- 0R0HLSEThermo Fisher Scientific Inc.249.57BMarket Cap+20.41%52-week change0.33P/E (Trailing)‪15.03%‬Profit Margin
- 0R2BLSEDanaher Corporation151.35BMarket Cap+5.96%52-week change0.25P/E (Trailing)‪15.94%‬Profit Margin
- 0JDMLSEIQVIA Holdings Inc.52.91BMarket Cap+29.36%52-week change0.48P/E (Trailing)‪8.09%‬Profit Margin
- 0HAVLSEAgilent Technologies Inc.49.36BMarket Cap+20.07%52-week change0.38P/E (Trailing)‪19.55%‬Profit Margin
Profile Summary - GENI - Genincode Plc
About
Genincode Plc is a biotechnology company specializing in the development and commercialization of advanced predictive genetic testing solutions. The primary function of Genincode Plc is to provide innovative and personalized healthcare solutions that focus on cardiovascular disease risk assessment. Through its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
